Inspire Medical Systems Inc (INSP) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Inspire Medical Systems Inc stock (INSP) is currently trading at $51.41. Inspire Medical Systems Inc PE ratio is 10.67. Inspire Medical Systems Inc PS ratio (Price-to-Sales) is 1.66. Analyst consensus price target for INSP is $78.46. WallStSmart rates INSP as Moderate Buy.
- INSP PE ratio analysis and historical PE chart
- INSP PS ratio (Price-to-Sales) history and trend
- INSP intrinsic value — DCF, Graham Number, EPV models
- INSP stock price prediction 2025 2026 2027 2028 2029 2030
- INSP fair value vs current price
- INSP insider transactions and insider buying
- Is INSP undervalued or overvalued?
- Inspire Medical Systems Inc financial analysis — revenue, earnings, cash flow
- INSP Piotroski F-Score and Altman Z-Score
- INSP analyst price target and Smart Rating
Inspire Medical Systems Inc
📊 No data available
Try selecting a different time range
INSP Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Inspire Medical Systems Inc (INSP)
INSP trades at a significant discount to its Graham intrinsic value of $228.38, offering a 70% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Inspire Medical Systems Inc (INSP) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Overall metrics suggest strong investment potential with favorable risk/reward.
Inspire Medical Systems Inc (INSP) Key Strengths (6)
Earnings per share surging 308.40% year-over-year
120.92% of shares held by major funds and institutions
Paying $1.66 for every $1 of annual revenue
Trading at 1.97x book value, attractively priced
Strong profitability: $16 kept per $100 revenue
Solid profitability: $20 profit per $100 equity
Supporting Valuation Data
Inspire Medical Systems Inc (INSP) Areas to Watch (3)
Small-cap company with higher risk but more growth potential
Decent operational efficiency, solid but not exceptional
Solid revenue growth at 12.20% per year
Supporting Valuation Data
Inspire Medical Systems Inc (INSP) Detailed Analysis Report
Overall Assessment
This company scores 68/100 in our Smart Analysis, earning a B- grade. Out of 9 metrics analyzed, 6 register as strengths (avg 8.5/10) while 3 fall into concern territory (avg 5.7/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.66), Price/Book (1.97) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 19.80%, Profit Margin at 16.00%. Growth metrics are encouraging with EPS Growth at 308.40%.
The Bear Case
The primary concerns are Market Cap, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at 12.20%, which may limit upside. Profitability pressure is visible in Operating Margin at 17.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Market Cap improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 19.80% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 12.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (EPS Growth, Institutional Own.) and negatives (Market Cap, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
INSP Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
INSP's Price-to-Sales ratio of 1.66x trades at a deep discount to its historical average of 24.65x (0th percentile). The current valuation is 98% below its historical high of 66.8x set in Oct 2021, and 0% above its historical low of 1.66x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~5.6x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Inspire Medical Systems Inc (INSP) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Inspire Medical Systems Inc is a mature, profitable business with steady cash generation. Revenue reached 912M with 12% growth year-over-year. Profit margins of 16.0% are healthy, with room for further expansion as the business scales.
Key Findings
Generating 42M in free cash flow and 52M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Inspire Medical Systems Inc.
Bottom Line
Inspire Medical Systems Inc is a well-established business delivering consistent profitability with 16.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(36 last 3 months)
| Insider | Type | Shares |
|---|---|---|
RONDONI, JOHN See Remarks | Sell | -109 |
Data sourced from SEC Form 4 filings
Last updated: 2:34:45 PM
About Inspire Medical Systems Inc(INSP)
NYSE
HEALTHCARE
MEDICAL DEVICES
USA
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.